首页> 外文期刊>Journal of stroke and cerebrovascular diseases: The official journal of National Stroke Association >Primary Thrombectomy Versus Combined Mechanical Thrombectomy and Intravenous Thrombolysis in Large Vessel Occlusion Acute Ischemic Stroke
【24h】

Primary Thrombectomy Versus Combined Mechanical Thrombectomy and Intravenous Thrombolysis in Large Vessel Occlusion Acute Ischemic Stroke

机译:大血管闭塞急性缺血性卒中大血栓切除术与组合机械血栓切除术及静脉溶栓

获取原文
获取原文并翻译 | 示例
           

摘要

Mechanical thrombectomy (MT) in combination with intravenous thrombolysis (IVT) is the standard of care for patients with acute ischemic stroke with anterior circulation large vessel occlusion. The particular benefit of IVT in these patients is unknown. We performed a retrospective analysis of patients submitted to MT at our center between January 2015 and June 2017. Functional outcome was prospectively assessed using modified Rankin scale (mRS) at 3 months. A total of 234 patients were enrolled, 152 (65%) in the combined treatment group and 82 (35%) in the direct MT group. Patients receiving combined treatment had a higher frequency of intracranial internal carotid artery occlusion (48 [31.6%] versus 16 [19.5%], P = .048) and significantly less strokes of cardioembolic etiology (72 [47.4%] versus 57 [69.5%], P = .01). Other baseline characteristics did not differ between the 2 groups. Good functional outcome at 3 months (mRS 0-2) was trending toward being higher in patients in the combined treatment group (98 [64.9%] versus 42 [52.5%], P = .066). Rates of symptomatic intracranial hemorrhage (5 [3.3%] versus 4 [4.9%], P = .723) and mortality (15 [9.9%] versus 14 [17.5%], P = .099) did not differ between groups. In multivariate logistic regression analysis, we did not find a statistically significant association between the use of IVT and any of the outcomes studied. Our results suggest that combined treatment carries similar effectiveness and safety than direct MT. Randomized controlled trials regarding this subject are warranted.
机译:机械血栓切除术(MT)与静脉溶栓(IVT)组合是急性缺血性卒中患者的标准,前循环大容器闭塞。 IVT在这些患者中的特殊益处是未知的。我们对2015年1月至2017年6月在我们的中心提交给MT的患者进行了回顾性分析。在3个月内使用改进的Rankin规模(MRS)进行了功能结果。总共234名患者在联合治疗组中注册了152(65%),直接Mt组中的82(35%)。接受组合治疗的患者具有较高的颅内内颈动脉闭塞次数(48 [31.6%]而16 [19.5%],P = .048),并且心脏栓塞病因的表现明显减少(72 [47.4%]与57(69.5%)[69.5%] [69.5%] [69.5% ],p = .01)。其他基线特征在2组之间没有区别。 3个月(0-2夫人)在合并治疗组中的患者中培养良好的功能结果(98 [64.9%],p = .066)。症状颅内出血的速率(5 [3.3%]与4 [4.9%],p = .723)和死亡率(15 [9.9%]与14 [17.5%],p = .099)在组之间没有差异。在多变量逻辑回归分析中,我们在IVT的使用与所研究的任何结果之间没有找到统计上的重要关联。我们的研究结果表明,组合治疗携带类似的有效性和安全性。有关此主题的随机对照试验是有保证的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号